Forgot your password?
Haven't registered yet?
7 hours agoThe practice of disinfection of high-speed handpieces with 70% w/v alcohol: An evaluation
7 hours agoRisks, consequences, and prevention of falls of older people in oral healthcare centers
17 hours agoGlobal Efforts to Control TB Are Falling Short
1/9/2017 » 1/12/20172017 Dental Infection Control Boot Camp™
Pfizer Inc said on Tuesday the U.S. Food and Drug Administration had expanded the use of its best-selling pneumonia vaccine, Prevnar, to adults aged 18 through 49.
The vaccine, which is already approved for use in adults aged 50 and above, and children aged 6 weeks to 17 years, prevents invasive diseases caused by 13 Streptococcus pneumoniae strains.
OSAP Disclaimer | Please notify our webmaster of any problems with this website.
OSAP thanks its Super Sponsors for their support in 2016. Sponsorship does not imply endorsement by OSAP of a company's products or services.